COVID-19: European Medicines Agency's vaccines chief says it is 'increasingly difficult' to say no link between Oxford jab and rare blood clots

The European Medicines Agency's (EMA) head of vaccine strategy has said it is "increasingly difficult" to say there is "no cause and effect relationship" between the Oxford-AstraZeneca jab and "rare cases of unusual blood clots".